James Warren Huff

Insider Reports History

Entity
Individual
Location
C/O Reata Pharmaceuticals, Inc., 2801 Gateway Dr. Suite 150, Irving, TX
Signature
/s/ Tracy Herson, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Warren Huff:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REATA PHARMACEUTICALS INC Chief Executive Officer, Director Class A common stock 0 $172.03 Sep 26, 2023 By The 2021 JWH GRAT
REATA PHARMACEUTICALS INC Chief Executive Officer, Director Class A common stock 0 $172.03 Sep 26, 2023 Direct
REATA PHARMACEUTICALS INC Chief Executive Officer, Director Class B common stock 0 $172.03 Sep 26, 2023 Direct
REATA PHARMACEUTICALS INC Chief Executive Officer, Director Employee Stock Option (right to buy) 0 Sep 26, 2023 Direct

Insider Reports Filed by James Warren Huff

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RETA REATA PHARMACEUTICALS INC Sep 26, 2023 13 $0 4 Sep 26, 2023 Chief Executive Officer, Director
RETA REATA PHARMACEUTICALS INC Jul 6, 2023 3 $0 4 Jul 10, 2023 Chief Executive Officer, Director
RETA REATA PHARMACEUTICALS INC Mar 1, 2023 13 -$6.41M 4 Mar 3, 2023 Chief Executive Officer, Director
RETA REATA PHARMACEUTICALS INC Jan 3, 2023 2 $0 4 Jan 4, 2023 Chief Executive Officer, Director